Borrelia miyamotoi Antibodies (IgG, IgM), Immunoassay
Test Code
39684
86619 (x2)
Clinical Significance
Borrelia miyamotoi Antibodies (IgG, IgM), Immunoassay - Borrelia miyamotoi is a tick-borne bacterial organism that causes a nonspecific febrile illness that may be misdiagnosed as Lyme disease or other tick-borne infections. Positive antibody results suggest B. miyamotoi infection; however, other tick-borne organisms may induce cross-reactive antibodies. Negative IgG and IgM results do not exclude the possibility of B. miyamotoi infection.
Test Resources
Test Details
Methodology
Immunoassay (IA)
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Reference Range(s)
| B. miyamotoi Ab (IgG) | <1.00 Index |
| B. miyamotoi Ab (IgM) | <1.00 Index |
Alternative Name(s)
GLPQ,B. miyamotoi
Preferred Specimen(s)
1.5 mL serum
Minimum Volume
0.5 mL
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 7 days
- Refrigerated: 14 days
- Frozen: 30 days
Reject Criteria
Gross hemolysis • Grossly lipemic • Grossly icteric
Setup Schedule
1.5 mL serum
0.5 mL
Transport tube
Room temperature
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Gross hemolysis • Grossly lipemic • Grossly icteric